← Back to Search

Behavioural Intervention

AeviceMD for Asthma (APAM Trial)

N/A

Waitlist Available

Led By Irina Dralyuk, MD

Research Sponsored by Irina Dralyuk

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

APAM Trial Summary

This trial aims to use a wearable device called AeviceMD to monitor the breathing of pediatric asthma patients at home. By using this device, patients can better manage their asthma, and doctors can adjust treatments

Who is the study for?

This trial is for children with asthma. Participants should be currently managing their asthma and looking to improve control over the disease at home. They must be willing to use AeviceMD, a wearable monitor, as part of their treatment plan.Check my eligibility

What is being tested?

The study tests AeviceMD, a wearable device designed to monitor respiratory health in kids with asthma. It aims to help patients manage their condition better at home and provide doctors with data for optimizing treatment.See study design

What are the potential side effects?

Since AeviceMD is a monitoring device, it's not expected to have direct side effects like medications do. However, there may be discomfort or skin irritation from wearing the device.

APAM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To evaluate the effectiveness of implementing home monitoring technology for asthma patients in delivering care to patients and in extension determine, if Aevice Medical Device can improve home management of Asthma for pediatrics patients.

Secondary outcome measures

To determine if the AeviceMD is effective as a remote auscultation tool for the facilitation of teleconsultations.

APAM Trial Design

1Treatment groups

Experimental Treatment

Group I: AeviceMDExperimental Treatment1 Intervention

This is a single site, single arm, open label medical device (AeviceMD) pilot where only intervention groups will be recruited.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Irina DralyukLead Sponsor

AEvice Health Pte LtdOTHER

1 Previous Clinical Trials

35 Total Patients Enrolled

1 Trials studying Asthma

35 Patients Enrolled for Asthma

Irina Dralyuk, MDPrincipal InvestigatorCedars-Sinai Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a part of this research trial?

"To be eligible for this research study, individuals aged between 3 and 18 years with a confirmed asthma diagnosis are sought. Approximately 20 suitable candidates will be selected to partake in the trial."

Answered by AI

Are individuals who are older than 85 years old eligible to participate in this clinical trial?

"This clinical investigation is seeking participants aged between 3 and 18. There are a total of 159 trials catering to the pediatric population, whereas there are 270 trials designated for individuals over the age of 65."

Answered by AI

Are there any available vacancies for patient participation in this clinical trial?

"As per clinicaltrials.gov, the current trial is not in active recruitment. It was initially posted on March 1st, 2024 and last revised on March 14th, 2024. Although this specific study is not enrolling participants presently, there are a total of 408 ongoing trials actively seeking candidates for participation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

AeviceMD for Pediatric Asthma Management

Irina Dralyuk 2024. "AeviceMD for Pediatric Asthma Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06321471.